Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.37 |
| ▸ | FABP7 | O15540 | 2/20 | 0.35 |
| ▸ | MDM4 | O15151 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6855668 | 1.00 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6853795 | 0.84 | LMNA (0.39) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL8729183 | 0.84 | LMNA (0.39) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL8729229 | 0.84 | LMNA (0.39) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL8732800 | 0.83 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6796420 | 0.79 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6858228 | 0.79 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6798554 | 0.79 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6849952 | 0.79 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A | |
| SCHEMBL6858226 | 0.79 | FABP5 (0.37) | FABP5FABP7MDM4TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828427-B1 | Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same | ISIS PHARMACEUTICALS, INC. | 2004-12-07 | — | — | US | disclosed |
| US-6184389-B1 | FEATURE A PLURALITY OF FUNCTIONAL GROUPS ATTACHED TO BACKBONE AND PHOSPHORAMIDATE SITES | ISIS PHARMACEUTICALS, INC. | 2001-02-06 | — | — | US | disclosed |